Smoothed rank regression with censored dataHELLER, Glenn.Journal of the American Statistical Association. 2007, Vol 102, Num 478, pp 552-559, issn 0162-1459, 8 p.Article

An adjustment for a post-randomization variable in the comparison of two treatments for survivalHELLER, Glenn.Statistics in medicine. 2001, Vol 20, Num 22, pp 3475-3485, issn 0277-6715Article

Picking the winners in a sea of plentySCHER, Howard I; HELLER, Glenn.Clinical cancer research. 2002, Vol 8, Num 2, pp 400-404, issn 1078-0432Article

A nonparametric test to compare survival distributions with covariate adjustmentHELLER, Glenn; VENKATRAMAN, E. S.Journal of the Royal Statistical Society. Series B, statistical methodology. 2004, Vol 66, pp 719-733, issn 1369-7412, 15 p., 3Article

Concordance probability and discriminatory power in proportional hazards regressionGÖNEN, Mithat; HELLER, Glenn.Biometrika. 2005, Vol 92, Num 4, pp 965-970, issn 0006-3444, 6 p.Article

The association between measures of progression and survival in castrate-metastatic prostate cancerSCHER, Howard I; WARREN, Mary; HELLER, Glenn et al.Clinical cancer research. 2007, Vol 13, Num 5, pp 1488-1492, issn 1078-0432, 5 p.Article

A competing-risks nomogram for sarcoma-specific death following local recurrenceKATTAN, Michael W; HELLER, Glenn; BRENNAN, Murray F et al.Statistics in medicine. 2003, Vol 22, Num 22, pp 3515-3525, issn 0277-6715, 11 p.Article

End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical PracticeSCHER, Howard I; MORRIS, Michael J; BASCH, Ethan et al.Journal of clinical oncology. 2011, Vol 29, Num 27, pp 3695-3704, issn 0732-183X, 10 p.Article

Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapyBERMAN, Ellin; LITTLE, Claudia; TESCHENDORF, Bonnie et al.Cancer. 2002, Vol 95, Num 5, pp 1064-1070, issn 0008-543XArticle

Neuroblastoma metastatic to the central nervous system: The memorial sloan-kettering Cancer Center experience and a literature reviewKRAMER, Kim; KUSHNER, Brian; HELLER, Glenn et al.Cancer. 2001, Vol 91, Num 8, pp 1510-1519, issn 0008-543XArticle

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVLHANASH, Alan M; KAPPEL, Lucy W; DUDAKOV, Jarrod A et al.Blood. 2011, Vol 118, Num 2, pp 446-455, issn 0006-4971, 10 p.Article

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate CancerSCHER, Howard I; XIAOYU JIA; MELUCH, Anthony A et al.Journal of clinical oncology. 2011, Vol 29, Num 16, pp 2191-2198, issn 0732-183X, 8 p.Article

Organ-derived dendritic cells have differential effects on alloreactive T cellsKIM, Theo D; TERWEY, Theis H; HELLER, Glenn et al.Blood. 2008, Vol 111, Num 5, pp 2929-2940, issn 0006-4971, 12 p.Article

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursorsZAKRZEWSKI, Johannes L; SUH, David; BRENTJENS, Renier J et al.Nature biotechnology (Print). 2008, Vol 26, Num 4, pp 453-461, issn 1087-0156, 9 p.Article

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the prostate-specific antigen working groupSCHER, Howard I; EISENBERGER, Mario; CARDUCCI, Michael A et al.Journal of clinical oncology. 2004, Vol 22, Num 3, pp 537-556, issn 0732-183X, 20 p.Article

Factors that affect final height and change in height standard deviation scores in survivors of Childhood Cancer treated with growth hormone: A report from the Childhood Cancer Survivor StudyBROWNSTEIN, Carrie M; MERTENS, Ann C; MITBY, Pauline A et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 9, pp 4422-4427, issn 0021-972X, 6 p.Article

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsIYER, Gopa; MORRIS, Michael J; HELLER, Glenn et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 1089-1097, issn 0344-5704, 9 p.Article

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerSOLIT, David B; IVY, S. Percy; LARSON, Steven et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1775-1782, issn 1078-0432, 8 p.Article

Androgen deprivation for minimal metastatic disease : Threshold for achieving undetectable prostate-specific antigenBEEKMAN, Kathleen; MORRIS, Michael; SLOVIN, Susan et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 5, pp 947-952, issn 0090-4295, 6 p.Article

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypesHSU, Katharine C; KEEVER-TAYLOR, Carolyn A; WILTON, Andrew et al.Blood. 2005, Vol 105, Num 12, pp 4878-4884, issn 0006-4971, 7 p.Article

Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancerRYAN, Charles J; ZELEFSKY, Michael J; HELLER, Glenn et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 1, pp 90-94, issn 0090-4295, 5 p.Article

Estimating survival benefit in castrate metastatic prostate cancer: Decision making in proceeding to a definitive phase III trialVERBEL, David Andrew; KELLY, W. Kevin; SMALETZ, Oren et al.Urology (Ridgewood, NJ). 2003, Vol 61, Num 1, pp 142-144, issn 0090-4295, 3 p.Article

Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-γ production and growth of cytotoxic precursorsKOEHNE, Guenther; SMITH, Katherine M; FERGUSON, Teresa L et al.Blood. 2002, Vol 99, Num 5, pp 1730-1740, issn 0006-4971Article

Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastomaKUSHNER, Brian H; HELLER, Glenn; KRAMER, Kim et al.Cancer. 2000, Vol 89, Num 10, pp 2122-2130, issn 0008-543XArticle

Analytic and Clinical Validation of a Prostate Cancer―Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for SurvivalDANILA, Daniel C; ANAND, Aseem; SCHER, Howard I et al.European urology. 2014, Vol 65, Num 6, pp 1191-1197, issn 0302-2838, 7 p.Article